First Wave BioPharma (NASDAQ: FWBI) experienced an impressive pre-market surge of approximately 85% on Thursday following the announcement of a licensing agreement with Sanofi (NASDAQ: SNY) concerning Capeserod, a potential treatment for gastrointestinal tract (GIT) disorders. The Agreement: According to the terms of the agreement, the biotech company based in Boca Raton, Florida, will obtain
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has recently seen a substantial intraday gain of over 15% in its share price. Despite the absence of any recent news or filings, this surge could suggest significant progress in the realm of allogeneic cell therapy. Background: The company is known for its regenerative approaches in various medical
Aurora Cannabis (NASDAQ: ACB) rockets over 70% intraday as it announced some significant news during after hours trading Friday September 8th, 2023. This news comes amongst strong times for the cannabis market, so it no doubt came with the rising tide of the macro backdrop. Here's a quick synopsis of the press release. The Release:
On August 8th, 2023, Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a leading developer in the psychedelic drug industry, witnessed an impressive surge in its stock value, gaining approximately 25% in combined trading, including after-hours (AH) trading. The British Columbia-based company made headlines by announcing its strategic move to acquire intellectual property (IP) from the renowned
Axcella Therapeutics (Nasdaq: AXLA) continues to gain traction the following week after their astonishing announcement, gaining over 40% at peak trading hours on August 7th, 2023. Their patent issuance represents a significant achievement, solidifying the company's global intellectual property position, here's a quick overview of the release. Quick Overview: The team at Axcella